The Clorox Company (NYSE:CLX) Shares Sold by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC trimmed its position in shares of The Clorox Company (NYSE:CLX) by 2.6% in the third quarter, HoldingsChannel reports. The institutional investor owned 15,268 shares of the company’s stock after selling 408 shares during the period. Mutual of America Capital Management LLC’s holdings in Clorox were worth $2,487,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in CLX. Innealta Capital LLC acquired a new stake in Clorox during the second quarter worth about $30,000. Trifecta Capital Advisors LLC raised its holdings in Clorox by 139.8% in the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after buying an additional 130 shares during the period. Family Firm Inc. acquired a new position in Clorox during the second quarter valued at approximately $31,000. Quarry LP grew its stake in Clorox by 99.1% during the second quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after buying an additional 114 shares during the period. Finally, EntryPoint Capital LLC acquired a new stake in shares of Clorox in the first quarter worth $39,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. This represents a 11.40 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.57% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on CLX. JPMorgan Chase & Co. upped their price target on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research report on Friday, October 11th. Deutsche Bank Aktiengesellschaft increased their target price on Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. Citigroup boosted their price target on Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and increased their price objective for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. Finally, TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and upped their target price for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Five analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $155.00.

Clorox Trading Up 0.1 %

Shares of NYSE CLX opened at $169.30 on Friday. The stock has a market capitalization of $20.96 billion, a P/E ratio of 58.99, a PEG ratio of 3.13 and a beta of 0.41. The stock’s 50 day moving average price is $162.78 and its two-hundred day moving average price is $148.48. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.35.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.64 billion. During the same period last year, the business posted $0.49 earnings per share. The firm’s revenue for the quarter was up 27.0% on a year-over-year basis. On average, analysts anticipate that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.88%. The ex-dividend date is Wednesday, January 29th. Clorox’s dividend payout ratio is presently 170.04%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.